Jin10 data, May 29 - Rongchang Bio announced that the company has successfully placed and issued a total of 19 million new H shares at a price of HKD 42.44 per share to no less than six subscribers on May 29, 2025, representing approximately 9.11% of the total issued H shares after the placement and issuance, and approximately 3.37% of the total issued shares. The total amount raised from the placement is approximately HKD 806 million, and the net amount that the company will receive from the placement (after deducting the Commission and estimated expenses) is approximately HKD 796 million.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Rongchang Bio: Successfully allocated and issued 19 million new H shares at a price of HKD 42.44 per share.
Jin10 data, May 29 - Rongchang Bio announced that the company has successfully placed and issued a total of 19 million new H shares at a price of HKD 42.44 per share to no less than six subscribers on May 29, 2025, representing approximately 9.11% of the total issued H shares after the placement and issuance, and approximately 3.37% of the total issued shares. The total amount raised from the placement is approximately HKD 806 million, and the net amount that the company will receive from the placement (after deducting the Commission and estimated expenses) is approximately HKD 796 million.